JAK Inhibitors

Joanna Broder

September 30, 2017

The selective Janus kinase-1 inhibitor filgotinib has shown initial efficacy and adequate safety for the treatment of rheumatoid arthritis.

Next post in Rheumatoid Arthritis

Cardiovascular Disease Risk Factors in Rheumatoid Arthritis Patients